These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 17045893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.
    Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie E, Gullestad L, Damås JK, Aukrust P.
    Cardiovasc Res; 2008 Jul 01; 79(1):195-203. PubMed ID: 18339644
    [Abstract] [Full Text] [Related]

  • 5. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
    Damås JK, Boullier A, Waehre T, Smith C, Sandberg WJ, Green S, Aukrust P, Quehenberger O.
    Arterioscler Thromb Vasc Biol; 2005 Dec 01; 25(12):2567-72. PubMed ID: 16224053
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization.
    Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P.
    Arterioscler Thromb Vasc Biol; 2007 Mar 01; 27(3):614-20. PubMed ID: 17170367
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.
    Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Frøland SS, Semb AG, Aukrust P, Damås JK.
    Circulation; 2004 Apr 27; 109(16):1966-72. PubMed ID: 15051633
    [Abstract] [Full Text] [Related]

  • 9. Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions.
    Baltus T, von Hundelshausen P, Mause SF, Buhre W, Rossaint R, Weber C.
    J Leukoc Biol; 2005 Aug 27; 78(2):435-41. PubMed ID: 15899984
    [Abstract] [Full Text] [Related]

  • 10. Potential anti-inflammatory role of activin A in acute coronary syndromes.
    Smith C, Yndestad A, Halvorsen B, Ueland T, Waehre T, Otterdal K, Scholz H, Endresen K, Gullestad L, Frøland SS, Damås JK, Aukrust P.
    J Am Coll Cardiol; 2004 Jul 21; 44(2):369-75. PubMed ID: 15261933
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis.
    Sandberg WJ, Halvorsen B, Yndestad A, Smith C, Otterdal K, Brosstad FR, Frøland SS, Olofsson PS, Damås JK, Gullestad L, Hansson GK, Oie E, Aukrust P.
    Circ Res; 2009 Jan 02; 104(1):60-8. PubMed ID: 19023130
    [Abstract] [Full Text] [Related]

  • 12. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
    Kälsch T, Nguyen XD, Elmas E, Grebert N, Süselbeck T, Klüter H, Borggrefe M, Dempfle CE.
    Int J Cardiol; 2006 Aug 10; 111(2):217-23. PubMed ID: 16182391
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.
    Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B.
    Circulation; 2007 Feb 27; 115(8):972-80. PubMed ID: 17283255
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
    Bjerkeli V, Damås JK, Fevang B, Holter JC, Aukrust P, Frøland SS.
    Rheumatology (Oxford); 2007 Sep 27; 46(9):1422-7. PubMed ID: 17616549
    [Abstract] [Full Text] [Related]

  • 17. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease.
    Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L.
    Am J Cardiol; 2005 Feb 15; 95(4):452-6. PubMed ID: 15695127
    [Abstract] [Full Text] [Related]

  • 18. Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis.
    Ueland T, Otterdal K, Lekva T, Halvorsen B, Gabrielsen A, Sandberg WJ, Paulsson-Berne G, Pedersen TM, Folkersen L, Gullestad L, Oie E, Hansson GK, Aukrust P.
    Arterioscler Thromb Vasc Biol; 2009 Aug 15; 29(8):1228-34. PubMed ID: 19498175
    [Abstract] [Full Text] [Related]

  • 19. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2.
    Traves SL, Smith SJ, Barnes PJ, Donnelly LE.
    J Leukoc Biol; 2004 Aug 15; 76(2):441-50. PubMed ID: 15155777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.